We are monitoring the impact of COVID-19 & Recession alarm on Latin America Neurotherapeutics Market Get in touch with us for detailed analysis Know More
Share on

Latin America Neurotherapeutics Market Research Report – Segmented By Treatment, Disorders, Distribution Channels & Country (Brazil, Argentina, Chile, Mexico and Rest of Latin America) – Industry Size, Share, Trends & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 1200
Pages: 132

The size of the Latin America Neurotherapeutics Market is predicted to rise at a steady CAGR between 2022 to 2027.  

An increase in the geriatric population base, advancing healthcare facilities, increased investments in R&D, and growing awareness about various nervous system disorders with a better understanding of associated drugs contribute to the growth of the neurotherapeutics market in the Latin American region. The elderly are more prone to brain disorders, which makes the growing geriatric population significantly impact the demand and sales of neurotherapeutics drugs. The World Health Organization has reported that by 2020, around 14.18% of the global population will suffer from some neurological disorder. This will stimulate the production of more neurotherapeutic drugs. Furthermore, the percentage of unspecified malignant tumors of the brain and CNS is remarkably high at around 33.6% in Central and South American regions.

Moreover, there is an increase in various brain disorders such as dementia, brain aneurysms, Parkinson’s disease. According to the WHO, mental health is one of the most common disorders in the present world, so healthcare officials depend on developing new drugs and better stimulation devices for treatment. In addition, according to the Neurological Association, due to the increase in life expectancy, dementia becomes more and more prevalent. An estimated 2.4 million Americans over the age of 65 will suffer from it by 2035.

Other factors such as the growing presence of significant healthcare players and ease of getting CE approval for various procedures will contribute to the growth of the Latin American neurotherapeutics market. There is enormous untapped potential for further growth in developing countries like Chile and Argentina. According to alz.org, Alzheimer’s disease is the fifth leading cause of death in Argentina and affects more than 305,000 Argentines. According to current data, over 44 million people have dementia, making this disease a global health crisis; this provides lucrative market growth opportunities during the forecast period.

However, the limited availability of other treatment options in drug therapy and surgeries is limiting the growth of the Latin American neurotherapeutics market. In addition, the absence of an adequate reimbursement policy, the presence of a complex regulatory framework, and lack of awareness in some developing countries are believed to challenge the growth of the Latin American neurotherapeutics market.

This research report on the Latin American neurotherapeutics market has been segmented and sub-segmented based on the following categories.

By Treatment:

  • Neurologic drugs
    • Oral administration
    • Injections
  • Neurologic devices
    • Electroconvulsive Therapy (ECT)
    • Vagus Nerve Stimulation (VNS)
    • Transcranial magnetic stimulation
    • Deep Brain Stimulator

By Disorders:

  • Central Nervous System (CNS) Disorders
  • Peripheral Nervous System (PNS) Disorders
  • Autonomous Nervous System (ANS) Disorders

By Distribution channels:

  • Hospitals
  • Neurotherapeutic Centre
  • Clinical research organizations
  • Clinics

By Country:

  • Mexico
  • Brazil
  • Argentina
  • Chile
  • Rest of Latin America

In 2020, the Brazilian market accounted for most of the Latin American neurotherapeutics market. This trend is expected to continue, owing to increased R&D activities, the presence of key market players, and the wide availability of technologically advanced devices. Besides, the increasing prevalence of various neurological disorders is another factor driving the market in this region. There is an increased prevalence of epilepsy and the like, with epilepsy recorded at 7.88 / 1000 inhabitants and the overall prevalence rate of active epilepsy was 5.68 / 1000 inhabitants.

On the other hand, it is estimated that other Latin American regions will also see a reasonable growth rate in the years to come. The Mexican region will register the fastest growth during the forecast period, owing to increased healthcare expenditure, the strong presence of major market players, and rapid technological advancements. As a result, there is a rapid increase in various CNS disorders during the forecast period 2022-2027. Six studies focusing on the prevalence of epilepsy in Mexico were found, reporting rates from 3.98 to 42.29 per 1,000 population. In contrast, other studies found high proportions of poor quality of life and impaired healthcare burden among Mexican patients and their families. All these factors will be responsible for the growth of the studied market during the forecast period.

KEY MARKET PLAYERS:

Some of the key players influencing the Latin America Neurotherapeutics Market are Abbott Laboratories, Inc., Becton, Novartis AG, Dickinson and Company, Pfizer, Inc., Johnson & Johnson, Biogen, Inc., GlaxoSmithKline, Inc., AstraZeneca plc, Sanofi-Aventis, Spiegelberg, Stryker, Covidien, Medtronic, GE healthcare, and Merck & Co.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Treatment                  

                                5.1.1 Introduction           

                                5.1.2 Neurologic Drugs 

                                                5.1.2.1 Oral Administration

                                                5.1.2.2 Injections

                                                5.1.2.3 Others

                                5.1.3 Neurologic Devices             

                                                5.1.3.1 Electroconvulsive Therapy (ECT)

                                                5.1.3.2 Vagus Nerve Stimulation (VNS)

                                                5.1.3.3 Transcranial magnetic stimulation

                                                5.1.3.4 Deep Brain Stimulator

                                                5.1.3.5 Others

                                5.1.4 Y-o-Y Growth Analysis, By Product

                                5.1.5 Market Attractiveness Analysis, By Product               

                                5.1.6 Market Share Analysis, By Product                

                5.2 Disorders                    

                                5.2.1 Introduction           

                                5.2.2 Central Nervous system disorder  

                                5.2.3 Peripheral Nervous system disorder            

                                5.2.4 Autonomous Nervous system disorder       

                                5.2.5 Y-o-Y Growth Analysis, By Type      

                                5.2.6 Market Attractiveness Analysis, By Type     

                                5.2.7 Market Share Analysis, By Type      

                5.3 Distribution Channels                            

                                5.3.1 Introduction           

                                5.3.2 Hospitals  

                                5.3.3 Neurotherapeutic center  

                                5.3.4 Clinical Research organisations      

                                5.3.5 Clinics        

                                5.3.6 Y-o-Y Growth Analysis, By Application         

                                5.3.7 Market Attractiveness Analysis, By Application        

                                5.3.8 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Treatment

                                                6.1.3.3 By Disorders

                                                6.1.3.4 By Distribution Channels

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Treatment

                                                6.1.4.3 By Disorders

                                                6.1.4.4 By Distributional Channels

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Treatment

                                                6.1.5.3 By Disorders

                                                6.1.5.4 By Distribution channels

                6.2 Brazil                             

                6.3 Mexico                         

                6.4 Rest of Latin America                             

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Abbott Laboratories               

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Becton                         

                8.3 Novartis AG                

                8.4 Dickinson and Company                       

                8.5 Pfizer                            

                8.6 Johnson & Johnson                 

                8.7 Biogen                          

                8.8 Glaxosmithkline                       

                8.9 AstraZeneca               

                8.10 Sanofi Aventis                        

                8.11 Spiegelberg                             

                8.12 Covidien                    

                8.13 Medtronic                

                8.14 GE Health Care                       

                8.15 Merck & Co                              

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. Latin America Neurotherapeutics Market, By Treatment, From 2022 - 2027 (USD Billion)
  2. Latin America Neurologic Drugs Market, By Region, From 2022 - 2027 (USD Billion)
  3. Latin America Neurologic Devices Market, By Region, From 2022 - 2027 (USD Billion)
  4. Latin America Neurotherapeutics Market, By Disorders, From 2022 - 2027 (USD Billion)
  5. Latin America Central Nervous system disorders Market, By Region, From 2022 - 2027 (USD Billion)
  6. Latin America Peripheral Nervous system disorders Market, By Region, From 2022 - 2027 (USD Billion)
  7. Latin America Autonomous Nervous system disorders Market, By Region, From 2022 - 2027 (USD Billion)
  8. Latin America Neurotherapeutics Market, By Distribution Channels, From 2022 - 2027 (USD Billion)
  9. Latin America Hospitals Market, By Region, From 2022 - 2027 (USD Billion)
  10. Latin America Neurotherapeutic center Market, By Region, From 2022 - 2027 (USD Billion)
  11. Latin America Clinical research organisations Market, By Region, From 2022 - 2027 (USD Billion)
  12. Latin America clinics Market, By Region, From 2022 - 2027 (USD Billion)
  13. Brazil Neurotherapeutics Market, By Treatment, From 2022 - 2027 (USD Billion)
  14. Brazil Neurotherapeutics Market, By Disorders, From 2022 - 2027 (USD Billion)
  15. Brazil Neurotherapeutics Market, By Distribution Channels, From 2022 - 2027 (USD Billion)
  16. Rest of Latin America Neurotherapeutics Market, By Treatment, From 2022 - 2027 (USD Billion)
  17. Rest of Latin America Neurotherapeutics Market, By Disorders, From 2022 - 2027 (USD Billion)
  18. Rest of Latin America Neurotherapeutics Market, By Distribution Channels, From 2022 - 2027 (USD Billion)
  19. Latin America Neurotherapeutics Market, By Neurologic drugs, From 2022 - 2027 (USD Billion)
  20. Latin America Oral Administrations Market, By Region, From 2022 - 2027 (USD Billion)
  21. Latin America Injections Market, By Region, From 2022 - 2027 (USD Billion)
  22. Brazil Neurotherapeutics Market, By Neurologic drugs, From 2022 - 2027 (USD Billion)
  23. Rest of Latin America Neurotherapeutics Market, By Neurologic drugs, From 2022 - 2027 (USD Billion)
  24. Latin America Neurotherapeutics Market, By Neurologic devices, From 2022 - 2027 (USD Billion)
  25. Latin America Electroconvulsive Therapy (ECT) Market, By Region, From 2022 - 2027 (USD Billion)
  26. Latin America Vagus Nerve Stimulation (VNS) Market, By Region, From 2022 - 2027 (USD Billion)
  27. Latin America Transcranial magnetic stimulation Market, By Region, From 2022 - 2027 (USD Billion)
  28. Latin America Deep Brain Stimulator Market, By Region, From 2022 - 2027 (USD Billion)
  29. Brazil Neurotherapeutics Market, By Neurologic devices, From 2022 - 2027 (USD Billion)
  30. Rest of Latin America Neurotherapeutics Market, By Neurologic devices, From 2022 - 2027 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

2875


pdf excel
$

3220


pdf excel powerbi
$

4600


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample